IATR — Athens Medical Center SA Income Statement
0.000.00%
Last trade - 00:00
- €147.45m
- €281.84m
- €233.42m
- 59
- 71
- 17
- 44
2018 December 31st | 2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 183 | 197 | 188 | 226 | 233 |
Cost of Revenue | |||||
Gross Profit | 45.8 | 47.8 | 40.5 | 57.8 | 56.8 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 167 | 181 | 180 | 205 | 215 |
Operating Profit | 16.2 | 16.7 | 7.89 | 21.4 | 18.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 9.41 | 10.8 | 3.62 | 15.3 | 10.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 10.8 | 7.67 | 2.43 | 12 | 6.92 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 10.8 | 7.59 | 3.92 | 15.1 | 6.85 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 10.8 | 7.59 | 3.92 | 15.1 | 6.85 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.124 | 0.086 | 0.027 | 0.15 | 0.078 |
Dividends per Share | |||||
Special Dividends per Share |